GUANGZHOU PHAR<0874> - Results Announcement (Summary)
Guangzhou Pharmaceutical Company Limited announced on 17/8/2001:
(stock code: 874)
Please refer to the press announcement for the details of the audit
committee's review report on the interim financial statement, to be issued
by the Company on 20/8/2001.
Year end date: 31/12/2001
Currency: RMB (Unaudited)
(Unaudited) Last
Current Corresponding
Period Period
from 1/1/2001 from 1/1/2000
to 30/6/2001 to 30/6/2000
('000) ('000)
Turnover : 2,644,971 2,150,903
Profit/(Loss) from Operations : 126,802 129,327
Finance cost : (18,843) (17,482)
Share of Profit/(Loss) of Associates : 286 471
Share of Profit/(Loss) of
Jointly Controlled Entities : (666) (539)
Profit/(Loss) after Tax & MI : 52,063 78,392
% Change over Last Period : -33.59%
EPS/(LPS)-Basic : RMB0.0645 RMB0.1070
-Diluted : - -
Extraordinary (ETD) Gain/(Loss) : - -
Profit/(Loss) after ETD Items : 52,063 78,392
Interim Dividend per H Share : NIL RMB0.02
(Specify if with other options) : - -
B/C Dates for Interim Dividend : N/A
Payable Date : N/A
B/C Dates for (-) General Meeting : N/A
Other Distribution for Current Period : N/A
B/C Dates for Other Distribution : N/A
Remark:
Profit from operations was previously reported as RMB111,845,000. The
change is due to change of format of current year form, which states the
profit from operations as before finance cost; while in last period,
Profit from operations was net of finance cost.
|
